Suppr超能文献

老年人群中无帕金森病患者的黑质病理与帕金森病体征。

Nigral pathology and parkinsonian signs in elders without Parkinson disease.

机构信息

Rush Alzheimer's Disease Center, Chicago, IL, USA.

出版信息

Ann Neurol. 2012 Feb;71(2):258-66. doi: 10.1002/ana.22588.

Abstract

OBJECTIVE

Motor symptoms such as mild parkinsonian signs are common in older persons, but little is known about their underlying neuropathology. We tested the hypothesis that nigral pathology is related to parkinsonism in older persons without Parkinson disease (PD).

METHODS

More than 2,500 persons participating in the Religious Orders Study or the Memory and Aging Project agreed to annual assessment of parkinsonism with a modified version of the Unified Parkinson Disease Rating Scale and brain donation. Brains from 744 deceased participants without PD were assessed for nigral neuronal loss and α-synuclein immunopositive Lewy bodies.

RESULTS

Mean age at death was 88.5 years. Mean global parkinsonism was 18.6 (standard deviation, 11.90). About ⅓ of cases had mild or more severe nigral neuronal loss, and about 17% had Lewy bodies. In separate regression models that adjusted for age, sex, and education, nigral neuronal loss and Lewy bodies were both related to global parkinsonism (neuronal loss: estimate, 0.231; standard error [SE], 0.068; p < 0.001; Lewy bodies: estimate, 0.291; SE, 0.133; p = 0.029). Employing a similar regression model that included both measures, neuronal loss remained associated with global parkinsonism (neuronal loss: estimate, 0.206; SE, 0.075; p = 0.006). By contrast, the association between Lewy bodies and global parkinsonism was attenuated by >60% and was no longer significant (Lewy bodies: estimate, 0.112; SE, 0.148; p = 0.447), suggesting that neuronal loss may mediate the association of Lewy bodies with global parkinsonism.

INTERPRETATION

Nigral pathology is common in persons without PD and may contribute to loss of motor function in old age.

摘要

目的

运动症状,如轻度帕金森氏症迹象,在老年人中很常见,但对于其潜在的神经病理学知之甚少。我们检验了这样一个假设,即黑质病理学与没有帕金森病(PD)的老年人的帕金森症有关。

方法

参加宗教秩序研究或记忆与衰老项目的 2500 多人同意每年用统一帕金森病评定量表的修订版评估帕金森症,并捐献大脑。对 744 名已故、没有 PD 的参与者的大脑进行了黑质神经元丢失和α-突触核蛋白免疫阳性路易体的评估。

结果

死亡时的平均年龄为 88.5 岁。平均全球帕金森症得分为 18.6(标准差 11.90)。大约三分之一的病例有轻度或更严重的黑质神经元丢失,约 17%有路易体。在分别调整年龄、性别和教育的回归模型中,黑质神经元丢失和路易体都与全球帕金森症有关(神经元丢失:估计值为 0.231;标准误差 [SE] 为 0.068;p < 0.001;路易体:估计值为 0.291;SE 为 0.133;p = 0.029)。在包含这两个指标的类似回归模型中,神经元丢失仍然与全球帕金森症有关(神经元丢失:估计值为 0.206;SE 为 0.075;p = 0.006)。相比之下,路易体与全球帕金森症之间的关联减弱了 60%以上,且不再显著(路易体:估计值为 0.112;SE 为 0.148;p = 0.447),这表明神经元丢失可能介导了路易体与全球帕金森症之间的关联。

解释

黑质病理学在没有 PD 的人中很常见,可能导致老年人运动功能丧失。

相似文献

1
Nigral pathology and parkinsonian signs in elders without Parkinson disease.
Ann Neurol. 2012 Feb;71(2):258-66. doi: 10.1002/ana.22588.
2
Association of Parkinson disease risk loci with mild parkinsonian signs in older persons.
JAMA Neurol. 2014 Apr;71(4):429-35. doi: 10.1001/jamaneurol.2013.6222.
3
Effects of Cerebrovascular and Lewy Body Pathology on Parkinsonian Signs in Community-Dwelling Older Adults.
Neurology. 2023 Aug 15;101(7):e754-e763. doi: 10.1212/WNL.0000000000207497. Epub 2023 Jul 12.
4
Locus coeruleus neuron density and parkinsonism in older adults without Parkinson's disease.
Mov Disord. 2012 Nov;27(13):1625-31. doi: 10.1002/mds.25142. Epub 2012 Oct 4.
7
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
J Neural Transm (Vienna). 2011 May;118(5):821-39. doi: 10.1007/s00702-010-0482-8. Epub 2010 Sep 23.
9
Lewy bodies and olfactory dysfunction in old age.
Chem Senses. 2011 May;36(4):367-73. doi: 10.1093/chemse/bjq139. Epub 2011 Jan 21.
10
Fragmentation of Golgi apparatus of nigral neurons with alpha-synuclein-positive inclusions in patients with Parkinson's disease.
Acta Neuropathol. 2006 Sep;112(3):261-5. doi: 10.1007/s00401-006-0114-4. Epub 2006 Jul 20.

引用本文的文献

1
Dopamine System Dysfunction in Alzheimer's Disease.
Psychogeriatrics. 2025 Sep;25(5):e70097. doi: 10.1111/psyg.70097.
6
7
Neural Metabolic Networks: Key Elements of Healthy Brain Function.
J Neurochem. 2025 Jun;169(6):e70084. doi: 10.1111/jnc.70084.
8
Exploring Risk and Protective Factors in Parkinson's Disease.
Cells. 2025 May 14;14(10):710. doi: 10.3390/cells14100710.

本文引用的文献

2
Gait alterations in healthy carriers of the LRRK2 G2019S mutation.
Ann Neurol. 2011 Jan;69(1):193-7. doi: 10.1002/ana.22165.
3
Parkinson's disease: genetics and pathogenesis.
Annu Rev Pathol. 2011;6:193-222. doi: 10.1146/annurev-pathol-011110-130242.
5
Association between mild parkinsonian signs and mortality in an elderly male cohort in China.
J Clin Neurosci. 2010 Feb;17(2):173-6. doi: 10.1016/j.jocn.2009.07.102. Epub 2010 Jan 6.
6
Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease.
Arch Neurol. 2009 Sep;66(9):1114-9. doi: 10.1001/archneurol.2009.170.
7
A critical evaluation of the Braak staging scheme for Parkinson's disease.
Ann Neurol. 2008 Nov;64(5):485-91. doi: 10.1002/ana.21541.
8
Quantitative brain measurements in community-dwelling elderly persons with mild parkinsonian signs.
Arch Neurol. 2008 Dec;65(12):1649-54. doi: 10.1001/archneurol.2008.504.
9
Incidental Lewy body disease and preclinical Parkinson disease.
Arch Neurol. 2008 Aug;65(8):1074-80. doi: 10.1001/archneur.65.8.1074.
10
A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
Neurobiol Aging. 2010 Jan;31(1):99-103. doi: 10.1016/j.neurobiolaging.2008.03.015. Epub 2008 May 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验